Interstitial high-dose rate brachytherapy as boost for anal canal cancer (Q34499551)

2 August 2017

Interstitial high-dose rate brachytherapy as boost for anal canal cancer (English)

1 reference

2 August 2017

1 reference

1 reference

Alexander Tuan Falk

1

1 reference

2 August 2017

Audrey Claren

2

1 reference

2 August 2017

Karen Benezery

3

1 reference

2 August 2017

Eric François

4

1 reference

2 August 2017

Mathieu Gautier

5

1 reference

2 August 2017

Jean-Pierre Gerard

6

1 reference

2 August 2017

Jean-Michel Hannoun-Levi

7

1 reference

2 August 2017

6 November 2014

1 reference

2 August 2017

1 reference

2 August 2017

9

1 reference

2 August 2017

240

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

start time

6 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13014-014-0240-4

0 references

cites work

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Role of interstitial brachytherapy in the treatment of malignant disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229617

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13014-014-0240-4

Dosimetric and clinical outcome in image-based high-dose-rate interstitial brachytherapy for anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13014-014-0240-4

Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13014-014-0240-4

Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13014-014-0240-4

Multimodal therapy of anal cancer added by new endosonographic-guided brachytherapy

21 January 2018

1 reference

12 December 2020

Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma

1 reference

12 December 2020

Interstitial curietherapy in the conservative treatment of anal and rectal cancers

1 reference

12 December 2020

Radiation therapy in the conservative treatment of carcinoma of the anal canal

1 reference

12 December 2020

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

1 reference

12 December 2020

Pulsed dose rate (PDR) brachytherapy of anal carcinoma

1 reference

12 December 2020

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

12 December 2020

Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy. Feasibility study of a French cooperative group

1 reference

12 December 2020

HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy

1 reference

12 December 2020

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial

1 reference

12 December 2020

Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study

1 reference

12 December 2020

10.1186/S13014-014-0240-4

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference